
Nisha Acharya
Professor, Proctor Foundation, Department of Ophthalmology, UCSF · University of California
Credentials: · · · ·
History
- Present
- Present
- 2001–2004
Ophthalmology
- 2000–2001
Preliminary or Transitional Year
Research
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
Ophthalmology · 2007 · 348 citations
American Journal of Ophthalmology · 2007 · Last of 8 authors · 313 citations
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole
JAMA Ophthalmology · 2013 · 263 citations

89 papers

46 papers

45 papers · 1 as a resident

37 papers

32 papers

27 papers

23 papers · 12 as a fellow

20 papers
Grants
- 2026–2031
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment (ADAPT) Trial
National Eye Institute · UG1
Contact PI · $1.7M · University of California, San Francisco
- 2018–2028
The Impact of the Herpes Zoster Vaccine on Herpes Zoster Ophthalmicus
National Eye Institute · R01
Contact PI · $4.5M · University of California, San Francisco
- 2024–2027
Programmable Phage Display Peptidomes to Characterize Uveitis
National Eye Institute · R21
PI · $451K · University of California, San Francisco
- 2019–2026
Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis Stopping Trial
National Eye Institute · UG1
Contact PI · $6.5M · University of California, San Francisco
Clinical trials
- 2026–2030
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
Principal investigator · Not yet recruiting · Phase 4
Nisha Acharya
- 2024–2025
Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases
Principal investigator · Completed
University of California, San Francisco
- 2020–2025
Adalimumab in JIA-associated Uveitis Stopping Trial
Principal investigator · Completed · Phase 4
Nisha Acharya
- 2018–2020
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
Principal investigator · Terminated · Phase 4
University of California, San Francisco


